We're a highly collaborative research group advancing innovative, sustainable solutions to eliminate malaria and lymphatic filariasis and strengthen vector-borne disease control in the Asia-Pacific region.
We’re a multi-disciplinary research group using epidemiological, immunological and implementation research to inform evidence-based public health programs. We aim to fill knowledge gaps, guide policy and scale innovative approaches. Our goal is to strengthen vector-borne disease control and advance the elimination of malaria and lymphatic filariasis.
We aim to eliminate malaria and lymphatic filariasis by strengthening vector-borne disease control through collaborative, multi-disciplinary research. We work closely with partners in Papua New Guinea, Solomon Islands, Vanuatu, Cambodia, Thailand, and Australia.
Our focus is on innovative approaches to public health challenges. For example, we develop novel diagnostics and surveillance tools to detect hidden reservoirs of infection, enabling more targeted malaria control. We integrate surveillance systems to rapidly identify emerging pathogens and resistant vectors. We evaluate new treatment and prevention strategies, including radical cure case management for Plasmodium vivax. We assess transmission-blocking interventions.
We also explore innovative vector control methods and invest in building the regional workforce to implement and sustain these strategies. Through genuine partnerships, we prioritise impactful, sustainable solutions. This then supports evidence-based policy change to scale up effective interventions.
Our overarching goal is to close critical knowledge gaps and accelerate progress toward the elimination of malaria and lymphatic filariasis.
We're working with partners to see how the 7-1-7 approach can help track and respond to disease outbreaks in the Pacific.
We work to increase access to new diagnostic tools for malaria, reduce health inequities and accelerate malaria elimination.
This project compares the performance of novel high sensitivity Plasmodium falciparum rapid diagnostic tests with conventional tests.
The project aims to to reduce malaria and other vector-borne infectious diseases in the South-Pacific i
Australia’s generation X face the highest risk of death from methamphetamine-related causes among all age groups, according to a new Burnet Institute study.